Mild cognitive impairment (MCI) is a heterogeneous condition with variable outcomes.
Improving diagnosis to increase the likelihood that MCI reliably reflects prodromal …

Degree of memory impairment is often used to infer early versus late amnestic mild cognitive
impairment (aMCI). Previously, 318 Alzheimer's Disease Neuroimaging Initiative participants …

Understanding the underlying qualitative features of memory deficits in mild cognitive
impairment (MCI) can provide critical information for early detection of Alzheimer's disease …

Background: New research criteria for diagnosing Alzheimer's disease (AD) in the mild
cognitive impairment stage (MCI-AD) incorporate biomarkers to assign a level of certainty to …

Medial temporal lobe (MTL) atrophy is considered to be one of the most important predictors
of Alzheimer's disease (AD). This study investigates whether atrophy in parietal and …

A published predictor model in a single-site cohort study (questionable dementia, QD) that
contained episodic verbal memory (SRT total recall), informant report of function (FAQ), and …

ABSTRACT Introduction Patients diagnosed with Mild Cognitive Impairment (MCI) often go
on to develop dementia, however many do not. Although cognitive tests are widely used in …

Our aim was to compare the predictive accuracy of 4 different medial temporal lobe
measurements for Alzheimer's disease (AD) in subjects with mild cognitive impairment …

Introduction Little empirical work has been done to examine differences between mild
cognitive impairment (MCI) diagnosed in research settings with longitudinal data (incident …

Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by
cognitive decline, functional disability, and neuropsychiatric symptoms. Initial diagnosis is …